Share Icon Health Study Area: Cardiovascular Disease Chevron Icon Health Study Area: Genitourinary For Patients Health Study Area: Lung Cancer Page Icon Phone Icon For Caregivers Health Study Area: AutoImmune Disease Health Study Area: Melanoma Location Icon Print YouTube Icon For Parents Health Study Area: Lung Cancer Print Created with Sketch. Help Icon Green Check Icon Search Icon Instagram Created with sketchtool. Direction Arrow Icon Error Icon For Parents Health Study Area: Blood Cancer Help Icon Health Study Area: NASH Gender Both Bookmark Icon Health Study Area: Melanoma Created with Sketch. Glossary Print Health Study Area: Blood Cancer Health Study Area: Genitourinary Health Study Area: Gastrointestinal Cancer Mobile Menu Icon Created with Sketch. Health Study Area: Cardiovascular Disease Health Study Area: Women's Cancer Communities Map Icon Created with Sketch. For Caregivers Health Study Area: Fibrosis Health Study Area: AutoImmune Disease FAQs Health Study Area: Head and Neck Cancer Created with Sketch. For Clinicians Chevron Right Icon Gender Female Health Study Area: Breast Cancer Direction Arrow Icon Gender Both Right Arrow Icon LinkedIn Icon Green Check Icon Gender Male Health Study Area: Fibrosis For Patients Twitter Icon Email Icon Facebook Icon Health Study Area: Gastrointestinal Cancer Health Study Area: Head and Neck Cancer For Clinicians External Link Icon
Search Study Connect

divider

Melanoma Knows No Color

Anyone can get Melanoma regardless of race or color. As part of the Bristol Myers Squibb (BMS) commitment to patient care, we continue to explore Melanoma through extensive clinical research. Learn more about our clinical research studies below.

divider

About our Melanoma Clinical Trial(s)

About our Melanoma Clinical Trial(s)

Approved medications are available that can slow the progression of Melanoma. However, not all melanomas respond, and the side effects sometimes outweigh the benefits. That's why researchers are working hard to develop more options - like those under investigation in our clinical research program. On this page you'll find information about Melanoma clinical trials for patients of all ethnicities and skin colors and active clinical trials.

Active Melanoma Trial(s)

Thank you for considering a Melanoma clinical trial. Click on the View Trials Details link to see more about any trial you're interested in and to check your eligibility.

The list of studies below may change as studies are added or removed due to completion, so please check back often.

  • Click on the View Trial Details link below each clinical trial to learn more about the study
  • Select any "Check Your Eligibility" button on the website and answer a few questions about your diagnosis to see if you are a potential match to any arthritis clinical trial and refer yourself to a recruiting trial site in a location convenient for you
  • Talk to your doctor ABOUT participating in a Melanoma clinicial trial

.

Melanoma and Skin of Color

A recent study of 649 people showed that

32% of Black patients

were diagnosed with Stage 3 or Stage 4 disease1

13% of White patients

were similarly diagnosed at such a late stage.

Research has shown that patients with skin of color are less likely than White patients to survive Melanoma.2

A research study has shown that the 5-year survival rates for skin cancer for the non-white population is

70% as compared to

92% for white patients.3

People with darker skin are more likely to get Melanoma in areas that don’t receive much sun exposure, such as thesole of your feet, palms of your hands, and fingernail beds.

Facts about Melanoma

Clinical Trials in Detail
Our "Participant's Discussion Guide to Cancer Clinical Trials" has information about how clinical trials work.
Download the Guide
Melanoma by the Numbers
Facts and figures about Melanoma
Read More
Discussing Melanoma with Your Doctor
Topics you might want to discuss with your doctor,
Download Discussion Guide

A Commitment to Increasing Diversity

A Commitment to Increasing Diversity

Bristol Myers Squibb is united by our mission to transform patient’s lives through science by discovering, developing, and delivering innovative medicines that help prevail over serious diseases. To that end, we are committed to doing our part to help ensure patients have a fair and just opportunity to achieve optimal health outcomes.

We are working to improve the recruitment of diverse patients with the goal that the clinical trial population becomes more reflective of the real-world population and the people impacted by the diseases studied.

.

.

We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information

Have questions? Live support is available 24/7 - Call 855-907-3286 or email clinical.trials@bms.com

Have questions? Live support is available 24/7 -
Call 855-907-3286 or email clinical.trials@bms.com